These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 4542537)

  • 1. [Josamycin propionate. 1. Physicochemical and biological properties].
    Osono T; Yano K; Murakami K; Miyamoto F; Murakami K
    Jpn J Antibiot; 1973 Apr; 26(2):115-21. PubMed ID: 4542537
    [No Abstract]   [Full Text] [Related]  

  • 2. Antibiotic susceptibility.
    Congeni B
    Pediatr Rev; 2009 Dec; 30(12):499-501. PubMed ID: 19952134
    [No Abstract]   [Full Text] [Related]  

  • 3. [Microbiological studies in the treatment of peritonitis].
    Fedorov VD; Lizgunova AV; Nikitin AM
    Khirurgiia (Mosk); 1971 Jan; 47(1):52-60. PubMed ID: 4930586
    [No Abstract]   [Full Text] [Related]  

  • 4. Maridomycin, a new macrolide antibiotic. 3. In vitro and in vivo antibacterial activity.
    Kondo M; Oishi T; Ishifuji K; Tsuchiya K
    J Antibiot (Tokyo); 1973 Apr; 26(4):206-14. PubMed ID: 4782049
    [No Abstract]   [Full Text] [Related]  

  • 5. [Evaluation of antibiotic activity. Clinical evaluation of data obtained in vitro from antibiograms].
    Giunchi G
    Antibiotica; 1966 Sep; 4(3):149-68. PubMed ID: 5991414
    [No Abstract]   [Full Text] [Related]  

  • 6. [Antibacterial properties of lincomycin in vitro and its chemotherapeutic activity].
    Shorin VA; Pevzner NS
    Antibiotiki; 1968 Sep; 13(9):810-5. PubMed ID: 4387685
    [No Abstract]   [Full Text] [Related]  

  • 7. Antimicrobial therapy for otitis media with effusion ("secretory" otitis media).
    Bluestone CD
    Pediatr Ann; 1984 May; 13(5):405-10. PubMed ID: 6539904
    [No Abstract]   [Full Text] [Related]  

  • 8. Tolypomycin, a new antibiotic. V. In vitro and in vivo antimicrobial activity.
    Kondo M; Oishi T; Tsuchiya K
    J Antibiot (Tokyo); 1972 Jan; 25(1):16-24. PubMed ID: 4110839
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical outcome of pneumococcal bacteremia, in vitro resistance, and antibiotic therapy.
    Torres-Tortosa M; Caballero-Granado J; Canueto J; Moreno-Maqueda I
    Clin Infect Dis; 2004 Mar; 38(5):763-4; author reply 765-6. PubMed ID: 14986265
    [No Abstract]   [Full Text] [Related]  

  • 10. Clindamycin (Dalacin C).
    Drug Ther Bull; 1970 Aug; 8(17):67-8. PubMed ID: 5480245
    [No Abstract]   [Full Text] [Related]  

  • 11. LL-AV290, a new antibiotic. II. Antibacterial efficacy in mice and in vitro.
    Redin GS; Dornbush AC
    Antimicrob Agents Chemother (Bethesda); 1968; 8():246-8. PubMed ID: 5735367
    [No Abstract]   [Full Text] [Related]  

  • 12. [The antimicrobial activities of maidimeisu (author's transl)].
    Want TL; Wang CD; Yan GH
    Yao Xue Xue Bao; 1980 Apr; 15(4):223-7. PubMed ID: 7457139
    [No Abstract]   [Full Text] [Related]  

  • 13. [Bacteriological studies on the treatment of surgical infections with Framycetin].
    Weber HG
    Med Klin; 1965 Oct; 60(40):1624-8. PubMed ID: 5882502
    [No Abstract]   [Full Text] [Related]  

  • 14. A new antibiotic, josamycin. II. Biological studies.
    Nitta K; Yano K; Miyamoto F; Hasegawa Y; Sato T
    J Antibiot (Tokyo); 1967 Jul; 20(3):181-7. PubMed ID: 6072799
    [No Abstract]   [Full Text] [Related]  

  • 15. [Efficacy of teicoplanin in 25 cases of severe infections caused by gram-positive cocci].
    Potel G; Touzé MD; Meignier M; Reynaud A; Baron D
    Pathol Biol (Paris); 1988 May; 36(5):531-5. PubMed ID: 2970058
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Antibiotics for recurrent acute otitis media in infants under two (author's transl)].
    Bláhová O; Drastík J
    Z Laryngol Rhinol Otol; 1973 Nov; 52(11):802-7. PubMed ID: 4149361
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinically useful antimicrobial agents. Selection of regimen.
    Postgrad Med; 1967 Nov; 42(5):420-33. PubMed ID: 6055006
    [No Abstract]   [Full Text] [Related]  

  • 18. Enduracidin, a new antibiotic. 3. In vitro and in vivo antimicrobial activity.
    Tsuchiya K; Kondo M; Oishi T; Yamazaki I
    J Antibiot (Tokyo); 1968 Feb; 21(2):147-53. PubMed ID: 4386300
    [No Abstract]   [Full Text] [Related]  

  • 19. [Value of quantitative bacteriological examination of sputum in the evaluation of the effectiveness of chemotherapy of bacterial respiratory tract infections. I. Bacteriological studies].
    Przybyłkiewicz Z; Nikodemowicz E; Kasprowicz A; Owsiński J
    Pneumonol Pol; 1980 Aug; 48(8):535-43. PubMed ID: 6775309
    [No Abstract]   [Full Text] [Related]  

  • 20. [Antibiotic therapy].
    Schmid F; Haus E; Schreiber A
    Fortschr Med; 1973 Apr; 91(10):430-4 contd. PubMed ID: 4700410
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.